Table 2.
Properties of monoclonal antibodies against MERS-CoV.
| Source | Ab | Binding affinity (Kd, nM) | IC50 (μg/ml) |
Efficacy | Reference | |
|---|---|---|---|---|---|---|
| Pseudotyped virus | Live virus | |||||
| Mouse hybridoma | 4C2 | 162 | ∼0.71 | 6.25 | ND | (Li et al., 2015) |
| 2E6 | 60.3 | ∼0.29 | 1.56 | ND | ||
| Humanized | 4C2h | 217 | ∼1.8 | 6.25 | 100% protection of Ad5-hCD26-transduced mice against virus infection | |
| Humanized mice | REGN3051 | 0.0433 | 0.0098 | 0.069 | 100% protection hCD26 mice from virus infection | (Pascal et al., 2015) |
| REGN3048 | 0.0485 | 0.011 | 0.027 | |||
| Phage-display (Fab) | m336 | 4.27 | 0.005 | 0.07 | 100% survival in rabbits when administered before challenge; no protection observed when given after challenge | (Houser et al., 2016; Ying et al., 2014) |
Kd, the equilibrium dissociation constant; IC50, 50% inhibitory concentration.